98 related articles for article (PubMed ID: 44898)
1. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
Mattioli G; Ricci S; Bertoncelli P
Minerva Cardioangiol; 1979; 27(7-8):463-72. PubMed ID: 44898
[No Abstract] [Full Text] [Related]
2. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
Mattioli G; Ricci S; Menozzi A; Teglio V
Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
[No Abstract] [Full Text] [Related]
4. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
Pedersen OL
Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
[No Abstract] [Full Text] [Related]
5. A comparative study of metoprolol and trichlormethiazide in hypertension.
Stokkeland OM; Sangvik K; Ditlefsen EM
Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
[No Abstract] [Full Text] [Related]
6. [Short-term effects of a treatment with methoprolol (a selective beta 1-blocking agent) in essential hypertension. Changes of haemodynamics, renin, aldosterone, sodium and potassium balance (author's transl)].
Novarini A; Bruschi G; Aurier E; Biggi A; Coruzzi P; Curti M; Rolli A; Borghetti A
G Ital Cardiol; 1979; 9(11):1259-67. PubMed ID: 399932
[No Abstract] [Full Text] [Related]
7. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
[No Abstract] [Full Text] [Related]
8. [Effects of arotinolol hydrochloride on hemodynamics, catecholamine levels and metabolism in patients with essential hypertension].
Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Konishi T; Hamada M; Nakano T
Kokyu To Junkan; 1988 Mar; 36(3):311-5. PubMed ID: 2453908
[No Abstract] [Full Text] [Related]
9. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
Zonis BIa; Brin VB
Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
[No Abstract] [Full Text] [Related]
10. Studies with a new cardioselective beta-blocker, metoprolol.
Werkö L; Aurell M; Johnsson G; Sannerstedt R; Svedmyr N
Adv Clin Pharmacol; 1976; 11():19-25. PubMed ID: 1032569
[TBL] [Abstract][Full Text] [Related]
11. [Changes in hemodynamics and renal function during the oral administration of betaxolol].
Pathe M; Schwartz J
Therapie; 1985; 40(4):209-12. PubMed ID: 2862715
[No Abstract] [Full Text] [Related]
12. [Use of Cordanum in labile hypertension].
Gerasimiuk PP; Zaporozhets TF; Slobodianik GP
Vrach Delo; 1982 Nov; (11):29-30. PubMed ID: 6130655
[No Abstract] [Full Text] [Related]
13. [Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
Caimi G; Frazzetta F; Capobianco D; Catania A; Francavilla G; Sarno A
Clin Ter; 1982 Nov; 103(4):383-8. PubMed ID: 7151384
[No Abstract] [Full Text] [Related]
14. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
[TBL] [Abstract][Full Text] [Related]
15. [Non-invasive evaluation of some hemodynamic effects of metoprolol].
Saettone G; Muzio L
Boll Soc Ital Cardiol; 1981; 26(12):2119-21. PubMed ID: 7185378
[No Abstract] [Full Text] [Related]
16. Prorenin and beta-blockade in hypertension.
McKenna F; Davison AM
Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
[TBL] [Abstract][Full Text] [Related]
17. Comparative review of beta-blocking agents.
Jackson EA; Sullman SA
Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
[No Abstract] [Full Text] [Related]
18. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
19. Seven years on a selective beta-blocker - metoprolol. A long-term study of women with arterial hypertension.
Bengtsson C
Ann Clin Res; 1981; 13 Suppl 30():7-15. PubMed ID: 6117244
[TBL] [Abstract][Full Text] [Related]
20. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
O'Callaghan EG
Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
